HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance

HealthEquity (NASDAQ: HQY) reported Q2 EPS of $1.24, $0.05 better than the analyst estimate of $1.19. Revenue for the quarter came in at $350.73 million versus the consensus estimate of $349.22 million.

GUIDANCE:

HealthEquity sees FY2027 EPS of $4.66-$4.73, versus the consensus of $4.72. HealthEquity sees FY2027 revenue of $1.41-1.42 billion, versus the consensus of $1.41 billion.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip
• Hormel Foods (HRL) Tops Q3 EPS by 2c, Misses on Revenue; Offers FY26 Guidance
• Dollar Tree (DLTR) Tops Q2 EPS by $1.59, Beats on Revenue; Offers FY Guidance